Simvastatin improved arterial compliance in high-risk patients

Vascular and Endovascular Surgery

Volumn 38, Issue 6, 2004, Pages 519-523

  Saliashvili, Gocha ^a,b   Davis, Warren W ^a,b,c   Harris, Matthey T ^a,b   Le, Ngoc Anh ^a,b,c   Brown, W Virgil ^a,b,c  

^a Emory University School of Medicine ^*

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; AGED; ANAMNESIS; ARTERIOSCLEROSIS; ARTERY COMPLIANCE; ARTICLE; BLOOD VESSEL TONE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG INDICATION; FEMALE; GASTROCNEMIUS MUSCLE; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; MALE; PATIENT MONITORING; PLETHYSMOGRAPHY; REVASCULARIZATION; RISK REDUCTION; SMOOTH MUSCLE TONE; THIGH; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ARTERIES; COMPLIANCE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PLETHYSMOGRAPHY; SIMVASTATIN;

EID: 10344230416     PISSN: 15385744     EISSN: None     Source Type: Journal    
DOI: 10.1177/153857440403800605     Document Type: Article

References (20)

1. Blacher J, Asmar R, Djane S, et al: Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 33:1111-1117, 1999.
2. Oliver J, Webb D: Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 23:554-566, 2003.
3. Wilkinson IB, MacCallum H, Rooijmans DF, et al: Inhibition of nitric oxide synthesis increases arterial stiffness in man. Hypertension 32:618, 1998.
4. Smilde TJ, van den Berkmortel FW, Wollersheim H, et al: The effect of cholesterol lowering on carotid and femoral artery wall stiffness and thickness in patients with familial hypercholesterolaemia. Eur J Clin Invest 30:473-480, 2000.
5. Tomochika Y, Okuda F, Tanaka N, et al: Improvement of atherosclerosis and stiffness of the thoracic descending aorta with cholesterol-lowering therapies in familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 16:955-962, 1996.
6. Giannattasio C, Mangoni AA, Failla M, et al: Impaired radial artery compliance in normotensive subjects with familial hypercholesterolemia. Atherosclerosis 124:249-260, 1996.
7. Shige H, Dart A, Nestel P: Simvastatin improves arterial compliance in the lower limb but not in the aorta. Atherosclerosis 155:245-250, 2001.
8. O'Driscoll G, Green D, Taylor R: Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 95: 1126-1131, 1997.
9. Tsunekawa T, Hayashi T, Kano H, et al: Cerivastatin, a hydroxymethylglutaryl coenzyme A reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days. Circulation 104:376-379, 2001.
10. Herrington D, Kesler K, Reiber J, et al: Arterial Compliance adds to conventional risk factors for prediction of angiographic coronary artery disease. Am Heart J, in press.
11. Willens H, Davis W, Wade K, et al: Relationship of peripheral arterial compliance and standard cardiovascular risk factors. Vasc Endovasc Surg 37:197-206, 2003.
12. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Circulation 106:3145-3421, 2002.
13. Herrington D, Brown WV, Moscal L, et al: Relationship between arterial stiffness and subclinical atherosclerosis. Circulation, in press.
14. Aikawa M, Sugiyama S, Hill C, et al: Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma. Circulation 2002;106:1390-1396.
15. Laufs U, La Fata V, Plutzky J, et al: Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97:1129-1135, 1998.
16. Laufs U, Liao JK: Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 273:24266-24271, 1998.
17. Christ M, Bauersachs J, Liebetrau C, et al: Glucose increases endothelial-dependent superoxide formation in coronary arteries by NAD(P)H oxidase activation: Attenuation by the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatin. Diabetes 51:2648-2652, 2002.
18. Tamai O, Matsuoka H, Itabe H, et al: Single LDL apheresis improves endothelium-dependent vasodilation in hypercholesterolemic humans. Circulation 95:76-82, 1997.
19. Wilkinson IB, Qasem A, McEniery C, et al: Nitric oxide regulates local arterial distensibility in vivo. Circulation 105:213-217, 2002.
20. Kinlay S, Creager M, Fukumoto M, et al: Endothelium-derived nitric oxide regulates arterial elasticity in human arteries in vivo. Hypertension 38:1049-1053, 2001.